{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:09:24Z","timestamp":1782601764372,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T00:00:00Z","timestamp":1422662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00330-014-3566-2","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T21:46:06Z","timestamp":1422654366000},"page":"1786-1792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance"],"prefix":"10.1007","volume":"25","author":[{"given":"Tae Heon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Kyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Kwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Hwan","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwang Gyun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byong Chang","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Il","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,31]]},"reference":[{"key":"3566_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4111\/kju.2013.54.7.417","volume":"54","author":"AS Glass","year":"2013","unstructured":"Glass AS, Punnen S, Cooperberg MR (2013) Divorcing diagnosis from treatment: contemporary management of low-risk prostate cancer. Korean J Urol 54:417\u2013425","journal-title":"Korean J Urol"},{"key":"3566_CR2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","volume":"271","author":"JI Epstein","year":"1994","unstructured":"Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271:368\u2013374","journal-title":"JAMA"},{"key":"3566_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11934-010-0110-z","volume":"11","author":"L Klotz","year":"2010","unstructured":"Klotz L (2010) Active surveillance for prostate cancer: a review. Curr Urol Rep 11:165\u2013171","journal-title":"Curr Urol Rep"},{"key":"3566_CR4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","volume":"61","author":"JI Epstein","year":"2012","unstructured":"Epstein JI, Feng Z, Trock BJ, Pierorazio PM (2012) Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol 61:1019\u20131024","journal-title":"Eur Urol"},{"key":"3566_CR5","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.juro.2008.11.107","volume":"181","author":"SL Conti","year":"2009","unstructured":"Conti SL, Dall\u2019era M, Fradet V, Cowan JE, Simko J, Carroll PR (2009) Pathological outcomes of candidates for active surveillance of prostate cancer. J Urol 181:1628\u20131633, discussion 1633-1624","journal-title":"J Urol"},{"key":"3566_CR6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/iju.12326","volume":"21","author":"TH Kim","year":"2014","unstructured":"Kim TH, Jeon HG, Choo SH et al (2014) Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols. Int J Urol 21:377\u2013381","journal-title":"Int J Urol"},{"key":"3566_CR7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","volume":"28","author":"L Klotz","year":"2010","unstructured":"Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A (2010) Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 28:126\u2013131","journal-title":"J Clin Oncol"},{"key":"3566_CR8","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1464-410X.2009.08597.x","volume":"104","author":"M Louie-Johnsun","year":"2009","unstructured":"Louie-Johnsun M, Neill M, Treurnicht K, Jarmulowicz M, Eden C (2009) Final outcomes of patients with low-risk prostate cancer suitable for active surveillance but treated surgically. BJU Int 104:1501\u20131504","journal-title":"BJU Int"},{"key":"3566_CR9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.eururo.2014.01.027","volume":"65","author":"RC Bergh van den","year":"2014","unstructured":"van den Bergh RC, Ahmed HU, Bangma CH, Cooperberg MR, Villers A, Parker CC (2014) Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review. Eur Urol 65:1023\u20131031","journal-title":"Eur Urol"},{"key":"3566_CR10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00330-010-1999-9","volume":"21","author":"SY Park","year":"2011","unstructured":"Park SY, Kim CK, Park BK, Lee HM, Lee KS (2011) Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results. Eur Radiol 21:1111\u20131118","journal-title":"Eur Radiol"},{"key":"3566_CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/RLI.0b013e31827b711e","volume":"48","author":"DM Somford","year":"2013","unstructured":"Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA et al (2013) Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer. Investig Radiol 48:152\u2013157","journal-title":"Investig Radiol"},{"key":"3566_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1148\/radiol.11091409","volume":"259","author":"T Hambrock","year":"2011","unstructured":"Hambrock T, Somford DM, Huisman HJ et al (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 259:453\u2013461","journal-title":"Radiology"},{"key":"3566_CR13","doi-asserted-by":"crossref","first-page":"374805","DOI":"10.1155\/2012\/374805","volume":"2012","author":"R Nagarajan","year":"2012","unstructured":"Nagarajan R, Margolis D, Raman S et al (2012) Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer. Adv Urol 2012:374805","journal-title":"Adv Urol"},{"key":"3566_CR14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.eururo.2008.11.051","volume":"56","author":"NJ As van","year":"2009","unstructured":"van As NJ, de Souza NM, Riches SF et al (2009) A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. Eur Urol 56:981\u2013987","journal-title":"Eur Urol"},{"key":"3566_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1259\/bjr\/14556365","volume":"84","author":"VA Morgan","year":"2011","unstructured":"Morgan VA, Riches SF, Thomas K et al (2011) Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance. Br J Radiol 84:31\u201337","journal-title":"Br J Radiol"},{"key":"3566_CR16","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.eururo.2007.05.011","volume":"52","author":"RC Bergh van den","year":"2007","unstructured":"van den Bergh RC, Roemeling S, Roobol MJ, Roobol W, Schroder FH, Bangma CH (2007) Prospective validation of active surveillance in prostate cancer: the PRIAS study. Eur Urol 52:1560\u20131563","journal-title":"Eur Urol"},{"key":"3566_CR17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/1097-0142(20000901)89:5<1056::AID-CNCR15>3.0.CO;2-U","volume":"89","author":"M Noguchi","year":"2000","unstructured":"Noguchi M, Stamey TA, McNeal JE, Yemoto CE (2000) Assessment of morphometric measurements of prostate carcinoma volume. Cancer 89:1056\u20131064","journal-title":"Cancer"},{"key":"3566_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"3566_CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/0003-4819-156-8-201204170-00010","volume":"156","author":"PA Ganz","year":"2012","unstructured":"Ganz PA, Barry JM, Burke W et al (2012) National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med 156:591\u2013595","journal-title":"Ann Intern Med"},{"key":"3566_CR20","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1200\/JCO.2010.32.8112","volume":"29","author":"JJ Tosoian","year":"2011","unstructured":"Tosoian JJ, Trock BJ, Landis P et al (2011) Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 29:2185\u20132190","journal-title":"J Clin Oncol"},{"key":"3566_CR21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.eururo.2010.08.027","volume":"58","author":"MS Soloway","year":"2010","unstructured":"Soloway MS, Soloway CT, Eldefrawy A, Acosta K, Kava B, Manoharan M (2010) Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 58:831\u2013835","journal-title":"Eur Urol"},{"key":"3566_CR22","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.urology.2012.07.049","volume":"80","author":"P Motamedinia","year":"2012","unstructured":"Motamedinia P, RiChard JL, McKiernan JM, DeCastro GJ, Benson MC (2012) Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance. Urology 80:1070\u20131074","journal-title":"Urology"},{"key":"3566_CR23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.crad.2008.02.001","volume":"63","author":"NM deSouza","year":"2008","unstructured":"deSouza NM, Riches SF, Vanas NJ et al (2008) Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 63:774\u2013782","journal-title":"Clin Radiol"},{"key":"3566_CR24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4111\/kju.2013.54.4.234","volume":"54","author":"K Shigemura","year":"2013","unstructured":"Shigemura K, Yamanaka N, Yamashita M (2013) Can diffusion-weighted magnetic resonance imaging predict a high Gleason score of prostate cancer? Korean J Urol 54:234\u2013238","journal-title":"Korean J Urol"},{"key":"3566_CR25","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s00330-012-2430-5","volume":"22","author":"KW Doo","year":"2012","unstructured":"Doo KW, Sung DJ, Park BJ et al (2012) Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI. Eur Radiol 22:1812\u20131819","journal-title":"Eur Radiol"},{"key":"3566_CR26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.urolonc.2010.08.023","volume":"30","author":"TJ Guzzo","year":"2012","unstructured":"Guzzo TJ, Resnick MJ, Canter DJ et al (2012) Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urol Oncol 30:301\u2013305","journal-title":"Urol Oncol"},{"key":"3566_CR27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1464-410X.2012.11641.x","volume":"111","author":"JK Mullins","year":"2013","unstructured":"Mullins JK, Bonekamp D, Landis P et al (2013) Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance. BJU Int 111:1037\u20131045","journal-title":"BJU Int"},{"key":"3566_CR28","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/bju.12423","volume":"113","author":"BH Park","year":"2014","unstructured":"Park BH, Jeon HG, Choo SH et al (2014) Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance. BJU Int 113:864\u2013870","journal-title":"BJU Int"},{"key":"3566_CR29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2214\/AJR.12.10397","volume":"201","author":"AB Rosenkrantz","year":"2013","unstructured":"Rosenkrantz AB, Prabhu V, Sigmund EE, Babb JS, Deng FM, Taneja SS (2013) Utility of diffusional kurtosis imaging as a marker of adverse pathologic outcomes among prostate cancer active surveillance candidates undergoing radical prostatectomy. AJR Am J Roentgenol 201:840\u2013846","journal-title":"AJR Am J Roentgenol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-014-3566-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-014-3566-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-014-3566-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:59:50Z","timestamp":1559044790000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-014-3566-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,31]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["3566"],"URL":"https:\/\/doi.org\/10.1007\/s00330-014-3566-2","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,31]]}}}